Frapaise Francois-Xavier 4/A
4/A · OPTIMER PHARMACEUTICALS INC · Filed Jan 12, 2010
Insider Transaction Report
Form 4/AAmended
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2009-02-19+120,000→ 120,000 totalExercise: $10.85Exp: 2019-02-19→ Common stock (120,000 underlying)
Footnotes (2)
- [F1]1/4 of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.
- [F2]The expiration date was incorrectly reported on 2/23/2009 as 2/19/2009.